Save up -80% on Levomilnacipran

Note: this is a drug discount program, not an insurance plan.
RX BIN: 015558RX PCN: HTGroup ID: DDN6600Card Holder ID: DDN6600
Pharmacists and Patients support.

2019 Price of Fetzima

$406.1130 capsules/40 mg
price without discount in nearest pharmacy. Price may vary.

Claim your free Levomilnacipran discount card

We offer free Fetzima coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Levomilnacipran every time. What are you waiting for? Claim your prescription drug card now!

Walgreens pharmacy
Walgreens pharmacy
CVS pharmacy
CVS pharmacy
Walmart pharmacy
Walmart pharmacy
Ride AID pharmacy
Ride AID pharmacy
CVS Target pharmacy
CVS Target pharmacy
Kroger pharmacy
Kroger pharmacy

Get your Prescription


It’s safe and free


Buy drugs in pharmacy

save money

Save money each time

Levomilnacipran volume of distribution

* 387 – 473 L[apparent volume of distribution]

RX Prescription
Ask Your therapeut before taking any drugs.

About RX24Drugs

2018 Statistics

discount card

Discount Cards 16,000+


Clients Benefit 29%


Total savings $4,735,080

What is Levomilnacipran

Levomilnacipran is a selective serotonin and norepinephrine reuptake inhibitor. Chemically, levomilnacipran is the 1S,2R-enantiomer of milnacipran. FDA approved on July 25, 2013.

Levomilnacipran mechanism of action

The exact mechanism of the antidepressant action of levomilnacipran is unknown but is thought to be related to the potentiation of serotonin and norephinephrine in the central nervous system through inhibition of reuptake at serotonin and norepinephrine transporters.

Dosage forms of Levomilnacipran

Fetzima20mg10 capsules$129
Fetzima80mg28 capsules$350
Fetzima120mg90 capsules$1,069
Fetzima40mgdose pack$350

Prescription Generics


International Brands





Actavis Specialty Pharmaceuticals Co

CAS number






Affected organisms

Humans and other mammals

Indication of Levomilnacipran

Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor and is indicated for the treatment of major depressive disorder (MDD).

Toxicity of Levomilnacipran

The most common adverse reactions are nausea, constipation, hyperhidrosis, heart rate increase, erectile dysfunction, tachycardia, vomiting, and palpitations.

RX24 Drugs Disclaimer: consult your healthcare provider before buying a Levomilnacipran on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Levomilnacipran now!

What is Fetzima?

Fetzima is a selective antidepressant for serotonin and norepinephrine reuptake inhibitor (SNRI). Fetzima affects chemicals in the brain that may be unbalanced in people with depression.

Fetzima is used to treat major depressive disorder. A similar medicine called milnacipran (Savella) is used to treat a chronic pain disorder called fibromyalgia. Fetzima should not be used to treat fibromyalgia.

You should not use Fetzima if you have untreated or uncontrolled narrow-angle glaucoma. Do not use Fetzima if you have taken an MAO inhibitor in the last 14 days. Dangerous drug interactions can occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, fenelzine, rasagiline, selegiline, and tranylcypromine. Do not use a MAO inhibitor for 7 days after stopping this drug.

Some young people have thoughts about suicide when they first take an antidepressant. Your doctor will need to check your progress with regular visits while you are using Fetzima. Report any new or worsening symptoms to your doctor, such as: changes in mood or behavior, anxiety, panic attacks, sleep problems, or if you feel impulsivity, irritability, agitation, hostility, aggression, anxiety, hyperactivity (mentally or physically). Do not give this medicine to anyone under 18 without consulting a doctor. Fetzima is not approved for use in children.